Pure Biologics achieves key milestone with successful completion of Phase 0 study for PBA-0405 in cancer treatment

Pure Biologics today announced the successful completion of its Phase 0 clinical study for the novel cancer therapy, PBA-0405.

News

Inquiries

Pure Biologics establishes Doto Medical special purpose vehicle

2 December

2022

Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics establishes the Doto Medical special purpose vehicle and signs an agreement with the renowned international business advisor Clairfield Partners to accelerate the commercialization of the PB103 aptamer project.

Pure Biologics webinar – year summary and project updates

25 November

2022

Pure Biologics webinar – year summary and project updates

Webinar with the management.

Two Pure Biologics projects qualified for funding in the Medical Research Agency grant call

22 November

2022

Two Pure Biologics projects qualified for funding in the Medical Research Agency grant call

Two projects have been qualified for funding under the Medical Research Agency (Agencja Badań Medycznych) grant call for the development of targeted or personalized medicine based on cell therapies or protein products.